CORALVILLE, Iowa, Jan. 6, 2016 /PRNewswire/ -- CIVCO Medical Solutions, the leading provider of comprehensive motion management solutions for radiation oncology, is pleased to announce the appointment of Ron Vaske as vice president of finance and business analysis for the Radiation Oncology business unit.
Mr. Vaske comes to CIVCO with over 20 years of leadership experience in finance, accounting and business process, most recently with McKesson Corporation.
"Ron is joining CIVCO's radiation oncology leadership team as a seasoned professional with demonstrated financial management experience. He will help us ensure that we continue to be well-positioned to meet new challenges and opportunities," said Nat Geissel, CIVCO's senior vice president and general manager, radiation oncology. "We are extremely pleased to have him on the team."
Mr. Vaske is located at CIVCO's corporate location in Coralville, Iowa. He earned his Bachelor of Business Administration from Iowa State University in Ames.
CIVCO Medical Solutions has over 30 years of experience and offers cutting-edge medical technology to a diverse group of medical professionals. CIVCO's Radiation Oncology (RO) division designs, manufactures and markets comprehensive motion management solutions to improve patient outcomes and increase clinical productivity for head & neck, breast, lung, abdomen, prostate and other treatment sites. RO's products include couchtops and overlays for linear accelerators and imaging systems, advanced patient immobilization solutions, robotic patient positioning, advanced fiducial markers, and immobilization/positioning equipment and consumables. CIVCO offers patients and clinicians the newest and best technology available to improve patient care. Corporate information is available at www.CIVCO.com
For further information please contact:
Marketing Manager, Radiation Oncology
CIVCO Medical Solutions
COPYRIGHT © 2016. CIVCO IS A REGISTERED TRADEMARK OF CIVCO MEDICAL SOLUTIONS. ALL OTHER TRADEMARKS ARE PROPERTY OF THEIR RESPECTIVE OWNER. ALL PRODUCTS MAY NOT BE LICENSED IN ACCORDANCE WITH CANADIAN LAW. 2015C1055